Seeing Is Believing
Currently out of the existing stock ratings of Craig Bijou, 45 are a BUY (66.18%), 15 are a HOLD (22.06%), 8 are a SELL (11.76%).
Analyst Craig Bijou, currently employed at BAML, carries an average stock price target met ratio of 65.13% that have a potential upside of 23.09% achieved within 179 days.
Craig Bijou’s has documented 140 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RXST, Rxsight at 03-Apr-2025.
Analyst best performing recommendations are on RMED (RA MEDICAL SYSTEMS).
The best stock recommendation documented was for RMED (RA MEDICAL SYSTEMS) at 8/13/2019. The price target of $2500 was fulfilled within 7 days with a profit of $987.5 (65.29%) receiving and performance score of 93.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$600
$148.42 (32.87%)
$565
19 days ago
(18-Mar-2025)
5/6 (83.33%)
$116.05 (23.98%)
108
Buy
$605
$153.42 (33.97%)
$666
20 days ago
(17-Mar-2025)
37/40 (92.5%)
$116.2 (23.77%)
152
Buy
$675
$223.42 (49.48%)
$575
2 months 13 days ago
(24-Jan-2025)
4/5 (80%)
$90.95 (15.57%)
94
Buy
$670
$218.42 (48.37%)
$538
2 months 13 days ago
(24-Jan-2025)
29/30 (96.67%)
$85.95 (14.72%)
152
Buy
$711
$259.42 (57.45%)
$640
2 months 13 days ago
(24-Jan-2025)
15/17 (88.24%)
$126.95 (21.74%)
299
Which stock is Craig Bijou is most bullish on?
Which stock is Craig Bijou is most reserved on?
What Year was the first public recommendation made by Craig Bijou?